Bond Teva Pharma Industries 5.125% ( US88167AAQ40 ) in USD

Issuer	Teva Pharma Industries
Market price	100.467 % ▼
Country	Israel
ISIN code	US88167AAQ40 ( in USD )
Interest rate	5.125% per year ( payment 2 times a year)
Maturity	09/05/2029
Prospectus brochure in PDF format is unavailable at this time We will provide it as soon as possible
Minimal amount	/
Total amount	/
Cusip	88167AAQ4
Standard & Poor's ( S&P ) rating	BB ( Non-investment grade speculative )
Moody's rating	Ba1 ( Non-investment grade speculative )
Next Coupon	09/05/2026 ( In 166 days )
Detailed description	Teva Pharmaceutical Industries is a global pharmaceutical company specializing in generic and specialty medications, with a focus on central nervous system disorders, respiratory diseases, oncology, and women's health. This financial article provides an overview of a specific debt instrument issued by Teva Pharmaceutical Industries, a global pharmaceutical leader headquartered in Israel, widely recognized as one of the world's largest manufacturers of generic drugs alongside a significant portfolio of specialty medicines. Identified by ISIN US88167AAQ40 and CUSIP 88167AAQ4, this bond, originating from Israel, is currently quoted on the market at 98.8525% of its face value and is denominated in USD. It carries a fixed annual interest rate of 5.125%, with interest payments disbursed semi-annually (frequency 2), and is set to mature on September 5, 2029. The bond's credit risk profile is evaluated by major rating agencies, holding a BB rating from Standard & Poor's and a Ba1 rating from Moody's.